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Abstract
Background: The aim of this study was to investigate whether we could detect positive surgical margins during
open and laparoscopic radical prostatectomy by 5-aminolevulinic acid (ALA) photodynamic diagnosis (PDD) and
mapping of red fluorescence in human prostate cancer cells.
Methods: All 52 patients were diagnosed with prostate cancer by biopsy. They had a positive core in the apex or
highly suspicious positive margins. Open and laparoscopic radical prostatectomy was performed in 18 and 34 cases,
respectively. One gram of ALA solution was given intraoperatively, orally through a stomach tube. An endoscopic PDD
system, including a D-Light C, CCU Tricam SLII/3CCD CH Tricam-P PDD, and HOPKINS II Straight Forward Telescope 0°,
was used. The D-Light C light source was equipped with a band-pass filter. The CCU Tricam SLII/3CCD CHTricam-P PDD
video camera system was equipped with a long-pass filter. The laparoscopy optic component was equipped with a
yellow long-pass filter.
Results: One of the 52 patients had a red-fluorescent-positive margin of the excised whole prostate and the positive
surgical margin was histologically confirmed. In the section of excised prostate, we obtained 141 biopsied samples. The
sensitivity and specificity were 75.0 % and 87.3 %, respectively.
Conclusions: Intraoperative ALA-PDD is feasible. However, heat degeneration and length of positive surgical margin
have crucial influences on red fluorescence. In future, a randomized clinical trial should be carried out.
Background
The number of new prostate cancer cases in Japan has
shown a consistent increase due to widespread acceptance
of prostate-specific antigen (PSA) mass screening. The
number of prostate cancer cases in Japan reached ~42,000
in 2006 [1]. Radical prostatectomy for localized prostate
cancer is a highly effective standard treatment modality.
However, the rate of positive surgical margins for radical
prostatectomy was reported to be 14–26 % [2–5]. Positive
surgical margins in prostate cancer are a significant risk fac-
tor for biochemical recurrence and lead to unfavorable
prognosis [6–9].
5-Aminolevulinic acid (ALA) is a naturally occurring
metabolite that is a precursor of porphyrin in heme bio-
synthesis. Exogenous ALA leads to accumulation of
the potent photosensitizer protoporphyrin (Pp)IX in
mitochondria. PpIX is known to accumulate more in
malignant and proliferating tissues than in normal tis-
sues [10–14]. In this way, PpIX selectively accumu-
lates at a significant level in tumor cells. PpIX is an
effective photosensitizer and fluorescent substance in
heme biosynthesis.
5-ALA-mediated photodynamic diagnosis (PDD) is
used widely in various cancers, including bladder cancer.
If we could adapt this technique to PDD during radical
prostatectomy, we could improve the rate of positive
surgical margins. Zaak et al. and Adam et al. reported
the feasibility of intraoperative ALA-PDD for the detec-
tion of positive surgical margins [15, 16].
In this study, we focused on two aspects. The first was to
investigate the feasibility of intraoperative ALA-PDD for
the detection of positive surgical margins. The second was
to demonstrate the predominant accumulation of PpIX in
human prostate cancer cells compared to normal prostate
cells by the use of ALA-PDD on the divided surface of
excised prostate. Thus, we investigated the feasibility of in-
traoperative PDD using 5-ALA in prostate cancer.
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Intraoperative ALA-PDD with radical prostatectomy was
approved by the Ethical Committee of Kochi Medical
School, Japan in January 2008. We enrolled 52 patients
with histologically confirmed adenocarcinoma-type pros-
tate cancer in the Department of Urology, Kochi Medical
School Hospital between February 2009 and August 2012.
All patients were informed about the potential efficacy
and adverse events, such as skin photosensitivity, transient
elevation of serum aspartate aminotransferase (AST) and
alanine aminotransferase (ALT), nausea, and vomiting. All
patients gave written informed consent. The 52 patients
had a median age of 67.1 years (range, 56–76 years), initial
PSA level of 7.71 ng/ml (range, 0.008–76 ng/ml), and his-
tologically confirmed adenocarcinoma of the prostate apex
(positive core rate 31.4 %; range, 8.3–75 %), according to
the general rules for clinical and histological studies on
prostate cancer, or an expected ≥25 % probability of extra-
prostatic extension (25.9 %; range, 3–59 %) defined by the
Japan PC table (Preoperative nomogram developed for
clinically localized prostate cancer in Japan) [17]. Patients
were stratified according to the D’Amico classification into
low-, intermediate- and high-risk groups. Twenty-eight
patients were categorized as low risk, 13 as intermediate
risk, and 11 as high risk. All 52 patients underwent radical
prostatectomy; 10 received preoperative deprivation ther-
apy; 34 underwent endoscopic retroperitoneal radical pros-
tatectomy; and 18 underwent open retroperitoneal radical
prostatectomy according to the technique described by
Walsh [18]. The patient characteristics are shown in
Table 1.
Administration of 5-ALA
We administered ALA as a photosensitizer for ALA-PDD.
ALA hydrochloride (COSMO BIO, Tokyo, Japan) was
dissolved in 50 ml 5 % glucose solution. One gram of ALA
solution was given intraoperatively, orally through a stom-
ach tube.
System of PDD
An endoscopic PDD system (Karl Storz, Tuttlingen,
Germany), including a D-Light C, CCU Tricam SLII/3CCD
CH Tricam-P PDD, and HOPKINS II Straight Forward
Telescope 0°, was used. The light source, D-Light C
(300 W xenon arc lamp), was equipped with a band-pass
filter designed to transmit blue light (excitation wavelength,
375–445 nm; for excitation of fluorescence). The video
camera system, CCU Tricam SLII/3CCD CHTricam-P
PDD, was equipped with a long-pass filter designed
to block blue light (for observation of fluorescence;
fluorescence emission wavelength, 600–740 nm). The
laparoscopy optic component was equipped with a
yellow long-pass filter to reduce blue excitation light
and enhance the fluorescence color contrast. The light
source can be instantly switched between white light
mode for conventional observation and blue light mode
for fluorescence handled by a camera controller.
Intraoperative procedure
In open radical prostatectomy, we placed the PDD laparo-
scope into the surgical field under general anesthesia and
observed the surgical margins using the white and blue
light modes. Blue light illuminated the surgical margins of
the urethral, bladder, and rectal side, and enabled observa-
tion of the status of red fluorescence in the darkened oper-
ating room. To avoid unnecessary tissue removal, only the
fluorescence-positive region was biopsied, for ethical rea-
sons. When the fluorescence-positive region was close
to a surrounding organ, such as the urethral sphincter
and rectum wall, the region was removed as completely
as possible with attention being paid to functional pres-
ervation of the surrounding organ. We sampled red-
fluorescence-positive specimens and compared them with
the pathological results.
Examination of excised prostate
Soon after harvesting the whole prostate, we also per-
formed laparoscopic PDD to detect red-fluorescence-
positive surgical margins (base, apex, lateral, and rectal
side). If a red-fluorescence-positive area was observed in
the surgical margin of excised whole prostate, this area was
biopsied by cold-cup for pathological examination. Subse-
quently, we divided the excised prostate in the median
Table 1 Patients’ characteristics
Object 2009/2–2012/9
52cases of prostate with operation




Initial PSA (range) (ng/ml) 9.76 (3.07–86.69)
Pre-op PSA (range) (ng/ml) 7.71 (0.008–42.57)
Pre-op MAB (+/−) (cases) 10/42
Apex (biopsy) (+/−) (cases) 17/35
Probability of EPE (%) 25.9 (3–59)
in Japan PC table





Gleason score 2–6 30
in biopsy specimen (cases) 7 12
8–10 10
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direction. The divided surface of excised prostate was also
subjected to PDD. We separated the divided surface into
four areas, and one specimen that was fluorescence-
positive or -negative was biopsied by cold-cup in each
area. The fluorescence intensity in each specimen was
roughly divided into four categories (none, weak, mod-
erate and strong), which was previously used in a clin-
ical study on brain tumors performed by Miyoshi et al.
[19]. The histological results were determined by two
pathological specialists without knowledge of the re-
sults of fluorescence intensity.
Statistical analysis
The diagnostic accuracy of the divided surface in excised
prostate was calculated on the basis of comparison between
fluorescence intensity and pathological results according to
general rules for clinical and pathological studies on pros-
tate cancer.
Results
PDD inside surgical margin
All 52 patients underwent retropubic radical prostatec-
tomy and PDD. Eighteen patients underwent open rad-
ical prostatectomy and 34 underwent laparoscopic
radical prostatectomy. There were no red-fluorescence-
positive and pathologically positive surgical margins in-
side the surgical margin in either the laparoscopic or
open surgery group.
PDD in excised whole prostate
Soon after harvesting the prostate, we performed PDD on
the surgical margins of the excised whole prostate. One
case (Case 1 in Table 2) demonstrated a red-fluorescence-
positive surgical margin of the excised whole prostate on
the basal side. Pathologically, this area was classified as
Gleason score 6 adenocarcinoma (Fig. 1a). In this case
with a red-fluorescence-positive surgical margin, the linear
length of the positive surgical margin was 8.2 mm, without
heat degeneration (Fig. 2a). However, another two cases
had a pathological positive surgical margin with no red
fluorescence. The first case showed heat degeneration of
the surgical margin, with a 7-mm-long positive surgical
margin (Case 3 in Fig. 2a, Table 2). In the second case, the
positive surgical margin was only 1.5 mm long, without
heat degeneration (Case 2 in Fig. 2a, Table 2). Three cases
diagnosed as extraprostatic extension had no red fluor-
escence. In these cases, tumor cells were not present
on the surface of the prostate. In fact, tumor cells were
covered with prostatic capsule or peripheral fat tissue
(Fig. 2b, Table 2). Ultimately, the rate of false negativity
was 3.8 % in total. After examination of surgical mar-
gins, we divided the excised prostate from 29 cases and
biopsied each area by cold-cup with PDD. We obtained
141 biopsied samples in all. Fluorescence positivity was
found in 31 samples, while pathological positivity was
found in 20 samples (Fig. 1b). The overall sensitivity and
specificity were 75.0 % and 87.3 %, respectively (Table 3).
Discussion
The number of new cases of prostate cancer detected
by PSA screening is increasing every year; in particu-
lar, the number of low-risk cases with an indication
for surgery. Radical prostatectomy is the gold stand-
ard therapy for prostate cancer in low-risk patients.
The purpose of radical prostatectomy is to remove the
whole cancerous prostate. However, positive surgical mar-
gins after radical prostatectomy were detected in 14–26 %
of cases [2–5]. A histologically positive surgical margin is
a major risk factor for biochemical recurrence and disease
progression after radical prostatectomy. It was shown that
positive surgical margins were associated with a 2.6-fold
Table 2 Individual results of positive surgical margin and extraprostatic extension





























4 Laparoscopy none 6.87 30 low 3b 3 + 4 none Extraprostatic
extension
- 1.2
5 Laparoscopy none 11.93 21 high 3a 4 + 5 none Extraprostatic
extension
- 2.0
6 Laparoscopy none 21.15 59 intermediate 3a 4 + 3 none Extraprostatic
extension
- 3.3
MAB, Maximum androgen blockade, EPE; Extraprostatic extension
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increased unadjusted risk of prostate-cancer-specific mor-
tality [hazard ratio (HR) 2.55, 95 % confidence interval
(CI) 2.02–3.21], and remained an independent predictor
of prostate-cancer-specific mortality on multivariate ana-
lysis (HR 1.70, 95 % CI 1.32–2.18) in 65,633 patients who
underwent radical prostatectomy for prostate cancer [20].
Overall, we believe it is important to reduce positive surgi-
cal margins for cancer control.
Kriegmair et al. published the first report about the feasi-
bility of ALA-PDD for bladder cancer in 1996 [21]. Subse-
quently, Hungerhunber et al. reported a greater number of
cases and demonstrated the feasibility of ALA-PDD [22].
Fig. 1 PDD finding in surgical margin and divided surface of excised prostate. a. Fluorescence-positive area of excised whole prostate was
detected at the surgical margin in the base side (Gleason score 6). b. Longitudinal section in divided surface of excised prostate showed
fluorescence-positive area in the transitional zone (Gleason score 7)
Fig. 2 Association between pathological finding and red fluorescence in positive surgical margin and extraprostatic extension. a. In a case of heat
degeneration and short linear length (<3 mm) of positive surgical margin, red fluorescence was not observed. b. All 3 cases of extraprostatic extension
had no red fluorescence with tissue covering the tumor cells
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Zaak et al. reported the first experience of intraoperative
ALA-PDD for prostate cancer in 2008 [15], and revealed
its feasibility for detecting positive surgical margins. Adam
et al. and Ganzer et al. revealed the diagnostic accuracy,
with overall sensitivity and specificity of 56–75 % and
88.2–91.6 %, respectively [16, 23]. The present study
showed that one case had a red-fluorescence surgical mar-
gin of the excised whole prostate and a histologically con-
firmed positive surgical margin of Gleason score 6. Heat
degeneration using an electrical device and the length of
the positive surgical margin have a crucial influence on
ALA-PDD. Heat degeneration leads to damage of intracel-
lular PpIX, so we could not detect red fluorescence. Be-
sides these factors, we could not detect red fluorescence in
a case with a short positive surgical margin because the
total amount of PpIX in the tumor cells was small. In a
case with an 8.2-mm-long positive surgical margin, we
could detect red fluorescence, but not in a case with a 1.5-
mm margin. Therefore, it is possible that a positive sur-
gical margin length <3 mm makes it difficult to detect
red fluorescence in ALA-PDD. In cases of extraprostatic
extension, the tumor cells were not exposed on the sur-
face of the prostate and were covered with prostatic
capsule or peripheral fat tissue. The penetration of blue
light was low at 0.2 mm [24]. Blue light has difficulty
penetrating deeply into tissue and has a direct effect
only on the surface of tissue. Therefore, it is difficult to
detect red fluorescence on extraprostatic extension. In
conclusion, heat degeneration by an electric device and
short linear length of positive surgical margin constitute
limiting factors for ALA-PDD.
PDD of the divided surface of excised prostate could
detect prostate cancer cells with a high degree of accur-
acy. We have previously shown in vitro accumulation of
ALA-mediated PpIX in prostate cancer cell lines [25]. In
the present study of the divided surface, we could clinic-
ally identify red-fluorescence emission in human prostate
cancer cells and predominant accumulation of PpIX in
cancerous tissue. In contrast, we could not detect red-
fluorescence emission in normal prostate tissue. In terms
of the diagnostic accuracy of PDD in bladder cancer, the
overall sensitivity and specificity were 93.4 % and 58.9 %,
respectively [26]. Meanwhile, sensitivity and specificity
were 75.0 % and 87.3 %, respectively, in the divided surface
of prostate. In terms of the prognostic accuracy of prostate
cancer, there were lower sensitivity and higher specificity
than for bladder cancer. Thus, the diagnostic accuracy of
PDD varies according to the type of cancer. In addition,
false-positive findings in prostate cancer were observed in
basal hyperplasia with chronic inflammation similar to
bladder cancer. Considering the location of prostate can-
cerogenesis, the capsule of the prostate has little effect on
basal hyperplasia and chronic inflammation. Therefore,
false-positive findings have no significant effect on intra-
operative PDD.
This study showed preliminary results of intraopera-
tive ALA-PDD in radical prostatectomy. We conclude
that intraoperative ALA-PDD is feasible, but our study
was limited by clinical stage and heat degeneration. In
the future, a randomized trial should be carried out.
Conclusions
Intraoperative ALA-PDD for prostate cancer is helpful in
assessing the presence of residual tumor in the surgical
margins. Clearly, future randomized studies are needed to
examine high-risk prostate cancer patients.
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Table 3 Diagnostic accuracy of PDD in excised whole prostate
and divided surface of excised prostate
The surgical margin status of excised whole prostate
Red fluorescence positive surgical margin 1
Pathologically positive surgical margin 3
Pathologically extraprostatic extension 3
Pathological result of divided surface in excised prostate
Biopsy specimens in divided surface (samples) 141
Pathology results in divided surface (samples)
Normal 121
Adenocarcinoma 20
Gleason score 2-6 9
7 6
8-10 5
Diagnostic Accuracy of PDD in divided
surface of excised prostate
Positive fluorescence (samples/rate (%)) 31/22.0
Prediction accuracy (%) 48.4
Sensitivity (%) 75.0
Specificity (%) 87.3
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